Correlation Between Calmare Therapeutics and U Power

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Calmare Therapeutics and U Power at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Calmare Therapeutics and U Power into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Calmare Therapeutics and U Power Limited, you can compare the effects of market volatilities on Calmare Therapeutics and U Power and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Calmare Therapeutics with a short position of U Power. Check out your portfolio center. Please also check ongoing floating volatility patterns of Calmare Therapeutics and U Power.

Diversification Opportunities for Calmare Therapeutics and U Power

-0.04
  Correlation Coefficient

Good diversification

The 3 months correlation between Calmare and UCAR is -0.04. Overlapping area represents the amount of risk that can be diversified away by holding Calmare Therapeutics and U Power Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on U Power Limited and Calmare Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Calmare Therapeutics are associated (or correlated) with U Power. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of U Power Limited has no effect on the direction of Calmare Therapeutics i.e., Calmare Therapeutics and U Power go up and down completely randomly.

Pair Corralation between Calmare Therapeutics and U Power

If you would invest  28,700  in U Power Limited on September 19, 2024 and sell it today you would lose (28,035) from holding U Power Limited or give up 97.68% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy0.34%
ValuesDaily Returns

Calmare Therapeutics  vs.  U Power Limited

 Performance 
       Timeline  
Calmare Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Calmare Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Calmare Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.
U Power Limited 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in U Power Limited are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, U Power may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Calmare Therapeutics and U Power Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Calmare Therapeutics and U Power

The main advantage of trading using opposite Calmare Therapeutics and U Power positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Calmare Therapeutics position performs unexpectedly, U Power can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in U Power will offset losses from the drop in U Power's long position.
The idea behind Calmare Therapeutics and U Power Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Transaction History
View history of all your transactions and understand their impact on performance